日批在线视频_内射毛片内射国产夫妻_亚洲三级小视频_在线观看亚洲大片短视频_女性向h片资源在线观看_亚洲最大网

Global EditionASIA 中文雙語Fran?ais
China
Home / China / Health

'China solution' targets high-risk breast cancer

By Zhou Wenting in Shanghai | China Daily | Updated: 2025-12-26 09:03
Share
Share - WeChat

A large-scale study by Chinese researchers offers a new treatment path for patients with the most aggressive form of breast cancer, providing what experts call a "China solution" for a disease that has long been difficult to treat.

The trial focused on triple-negative breast cancer, often considered the most dangerous version of the disease because it lacks the three common "hooks" — or receptors — that most modern drugs use to identify and kill cancer cells. Because these hooks are missing, doctors have struggled to find targeted treatments that work for every patient, often leaving chemotherapy as the only option.

The study, conducted by researchers at Fudan University Shanghai Cancer Center, found that adding the chemotherapy drug carboplatin to the standard treatment plan significantly improved outcomes. Patients in the experimental group reached a three-year survival rate of 92.3 percent without recurrence, a notable improvement over the 85.8 percent seen in the control group.

The findings were published on Tuesday in the medical journal BMJ. The researchers named the study "Citrine", after the yellow gemstone that symbolizes hope. Triple-negative breast cancer accounts for about 25 percent of all breast cancer cases and is known for its high risk of recurrence, which is when the cancer comes back, or metastasis, which is when the cancer spreads to other organs within five years of the initial diagnosis.

Lead researcher Shao Zhimin, a chief expert at the cancer center, said the study aims to move away from a "one-size-fits-all" approach. He noted that even with standard follow-up care after surgery, many patients still experience the cancer returning or spreading to distant parts of the body. Shao said the goal is to identify high-risk patients early and provide personalized care.

The team began this clinical research in 2021, focusing on patients categorized as high risk. This includes people whose cancer had already spread to their lymph nodes — small glands that help the body filter waste and fight infection — or patients whose tumor cells were growing and dividing at an unusually fast rate.

In the trial, which involved more than 800 participants, the researchers found that the addition of carboplatin reduced the relative risk of the cancer returning by 36 percent. For those in the experimental group, the three-year overall survival rate reached an impressive 98 percent.

Shao explained that the extra medication provided a crucial buffer during the period immediately following surgery, which is the most vulnerable time for these patients.

Wang Zhonghua, the deputy head of the hospital's breast surgery department, added that the trial showed no new or unexpected safety risks, which provides a solid foundation for doctors to begin using this treatment method more widely in clinics.

Top
BACK TO THE TOP
English
Copyright 1994 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
 
主站蜘蛛池模板: 日本特黄一级片 | 中文字幕一区二区三区视频 | 午夜影院在线 | 国产成人黄色 | 亚洲三级av| 亚洲成人精品在线播放 | 日韩中文字幕在线视频 | av天天色 | 国产综合网站 | 亚洲欧美日韩久久 | 91视频麻豆 | 99视频精品在线 | 亚洲麻豆 | 欧美黄色大全 | 亚洲欧美日韩色 | 国产精品久久久999 成人激情视频在线 | 亚洲成年人在线观看 | 91精品久久久久久综合五月天 | 麻豆精品免费视频 | 美女久久视频 | 成人av三级| 亚洲高清视频在线 | 亚洲色图导航 | 色在线免费视频 | 午夜欧美在线 | 特级丰满少妇一级aaaa爱毛片 | 99精品一区 | 色婷婷777777仙踪林 | 国产精品成人网 | 日韩有码在线播放 | 欧美黄色录像视频 | 国产一区二区毛片 | 国产成人综合在线观看 | 高压监狱满天星在线观看 | 欧美亚洲视频 | 久久超碰av | 日韩v片 | 国产原创在线 | 国产99久久久 | 日本一二三区在线视频 | 免费视频久久 |